Robert F. Friel Elected PerkinElmer CEO
Robert F. Friel has been elected chief executive officer of PerkinElmer, Inc. (Waltham, MA).
Robert F. Friel has been elected chief executive officer of PerkinElmer, Inc. (Waltham, MA). He will also retain the title of president. Friel joined PerkinElmer in 1999 as chief financial officer, and was appointed vice chairman and president of its Life and Analytical Sciences business in 2006. In 2007, Friel was appointed president and chief operating officer of the company.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
